0

Dyslipidemia Collection
 1-20 of 31 Articles
ACP Journal Club |  18 December 2012
Review: Omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults
Donald A. Smith, MD, MPH, FACP, FNLA
Ann Intern Med. 2012;157(12):JC6-5. doi:10.7326/0003-4819-157-12-201212180-02005
ACP Journal Club |  18 December 2012
Review: Statins reduce pancreatitis in adults with normal or mildly elevated triglyceride levels
Hanna E. Bloomfield, MD, MPH
Ann Intern Med. 2012;157(12):JC6-8. doi:10.7326/0003-4819-157-12-201212180-02008
ACP Journal Club |  20 November 2012
Review: Lipid-lowering drugs decrease all-cause and cardiac mortality and CV events in CKD
G. V. Ramesh Prasad, MBBS, FRCPC
Ann Intern Med. 2012;157(10):JC5-5. doi:10.7326/0003-4819-157-10-201211200-02005
ACP Journal Club |  16 October 2012
Meta-analysis: Lowering LDL-C levels using statins reduces major vascular events regardless of baseline risk
Meera Jain, MD; Mark Rosenberg, MD
Ann Intern Med. 2012;157(8):JC4-2. doi:10.7326/0003-4819-157-8-201210160-02002
ACP Journal Club |  16 October 2012
Review: Quality improvement strategies reduce HbA1c, LDL cholesterol, and BP in diabetes
Sean F. Dinneen, MD; Máire O’Donnell, PhD
Ann Intern Med. 2012;157(8):JC4-11. doi:10.7326/0003-4819-157-8-201210160-02011
ACP Journal Club |  18 September 2012
Daily n-3 fatty acid supplements did not reduce CV events in high-risk patients with dysglycemia
Ellis Lader, MD
Ann Intern Med. 2012;157(6):JC3-11. doi:10.7326/0003-4819-157-6-201209180-02011
ACP Journal Club |  20 March 2012
Simvastatin reduced major vascular events at 5 years in at-risk patients; benefits were maintained at 11 years
Edward P. Havranek, MD
Ann Intern Med. 2012;156(6):JC3-5. doi:10.7326/0003-4819-156-6-201202210-02005
ACP Journal Club |  20 March 2012
Review: Statins do not increase risk for intracerebral hemorrhage
David C. Anderson, MD
Ann Intern Med. 2012;156(6):JC3-6. doi:10.7326/0003-4819-156-6-201202210-02006
ACP Journal Club |  17 January 2012
Review: Interventions to reduce or modify dietary fat reduce cardiovascular events
Scott Kahan, MD, MPH; Yoni Freedhoff, MD
Ann Intern Med. 2012;156(2):JC1-5. doi:10.7326/0003-4819-156-2-201201170-02005
ACP Journal Club |  20 December 2011
Review: Insufficient evidence exists to determine the benefits and risks of statins for acute ischemic stroke or TIA
Robert L. Trowbridge, MD
Ann Intern Med. 2011;155(12):JC6-6. doi:10.7326/0003-4819-155-12-201112200-02006
ACP Journal Club |  15 November 2011
Simvastatin plus ezetimibe reduced major atherosclerotic events in patients with chronic kidney disease
Maurice Laville, MD
Ann Intern Med. 2011;155(10):JC5-2. doi:10.7326/0003-4819-155-10-201111150-02002
ACP Journal Club |  18 October 2011
Review: Intensive-dose statin therapy increases incident diabetes compared with moderate-dose therapy
Elizabeth Barrett-Connor, MD
Ann Intern Med. 2011;155(8):JC4-7. doi:10.7326/0003-4819-155-8-201110180-02007
ACP Journal Club |  16 August 2011
Meta-analysis: High-dose statin pretreatment prevents periprocedural cardiac events in patients having PCI
Emil L. Fosbol, MD, PhD; Christopher B. Granger, MD
Ann Intern Med. 2011;155(4):JC2-8. doi:10.7326/0003-4819-155-4-201108160-02008
ACP Journal Club |  17 May 2011
Meta-analysis: More intensive statin therapy prevents major vascular events
Donald A. Smith, MD, MPH, FACP, FNLA, FACE
Ann Intern Med. 2011;154(10):JC5-3. doi:10.7326/0003-4819-154-10-201105170-02003
ACP Journal Club |  17 May 2011
Prescription omega-3 fatty acids did not prevent recurrent, symptomatic, paroxysmal or persistent atrial fibrillation
Brian Olshansky, MD
Ann Intern Med. 2011;154(10):JC5-9. doi:10.7326/0003-4819-154-10-201105170-02009
ACP Journal Club |  16 November 2010
Intensifying glucose control and adding fenofibrate to simvastatin each reduced progression of retinopathy in type 2 diabetes
David L. Bronson, MD, FACP
Ann Intern Med. 2010;153(10):JC5-10. doi:10.7326/0003-4819-153-10-201011160-02010
ACP Journal Club |  21 September 2010
Review: Statins do not reduce mortality in patients with no history of cardiovascular disease
David J. Maron, MD
Ann Intern Med. 2010;153(6):JC3-4. doi:10.7326/0003-4819-153-6-201009210-02004
ACP Journal Club |  20 July 2010
Fenofibrate plus simvastatin did not prevent major CV events more than simvastatin alone in type 2 diabetes
C. Raina Elley, MBChB, PhD; Vanessa Selak, MBChB, MPH
Ann Intern Med. 2010;153(2):JC1-5. doi:10.7326/0003-4819-153-2-201007200-02005
ACP Journal Club |  15 June 2010
Rosuvastatin prevented ischemic stroke in healthy older adults with elevated C-reactive protein
Salvador Cruz-Flores, MD, MPH
Ann Intern Med. 2010;152(12):JC6-6. doi:10.7326/0003-4819-152-12-201006150-02006
ACP Journal Club |  15 June 2010
Review: Statin use increases risk for diabetes
John-Michael Gamble, BScPharm, MSc; Sumit R. Majumdar, MD, MPH
Ann Intern Med. 2010;152(12):JC6-7. doi:10.7326/0003-4819-152-12-201006150-02007
Advertisement

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)